Desmopressin Acetate Tablets — Class II drug recall D-1171-2022
Terminated recall by Glenmark Pharmaceuticals Inc., USA, reported 2022-07-06, distributed in TX. CGMP Deviations
| Recall number | D-1171-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ, United States |
| Recall initiated | 2022-06-29 |
| Classified | 2022-06-30 |
| Reported by FDA | 2022-07-06 |
| Terminated | 2023-06-23 |
| Distributed | TX |
| Quantity | 36 bottles |
| Reason classes | cgmp |
| NDC | 16714-0884-01 |
| Lot numbers | 20020121 |
| Expiration dates | 2024-01 |
Product
Desmopressin Acetate Tablets, 0.2 mg, 100-count bottles, Rx Only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Colvale-Bardez, Goa 403513, India, NDC 16714-884-01
Reason for recall
CGMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1171-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.